Revuelta-López, Elena; Nunez, Julio; Gastelurrutia, Paloma; Cediel, German; Januzzi, James-L; Ibrahim, Nasrien-E; Emdin, Michele; VanKimmenade, Roland; Pascual-Figal, Domingo-Andrés; Nunez, Eduardo; Gommans, Frank; Lupon, Josép; Bayes-Genis, Antoni
(WILEY PERIODICALS, INC, 2020-04)
AIM: Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor developed for the treatment of heart failure with reduced ejection fraction. Its benefits are achieved through the inhibition of ...